Insider Transactions in Q3 2023 at Prothena Corp Public LTD CO (PRTA)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2023
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-95.96%
|
$235,000
$47.8 P/Share
|
|
Sep 27
2023
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$50,000
$10.27 P/Share
|
|
Sep 19
2023
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$260,000
$52.36 P/Share
|
|
Sep 19
2023
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$75,000
$15.04 P/Share
|
|
Sep 13
2023
|
Brandon S. Smith Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,000
-98.58%
|
$220,000
$55.72 P/Share
|
|
Sep 13
2023
|
Brandon S. Smith Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$44,000
$11.12 P/Share
|
|
Sep 13
2023
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-100.0%
|
$110,000
$55.48 P/Share
|
|
Sep 13
2023
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$48,000
$24.9 P/Share
|
|
Sep 06
2023
|
Carol D. Karp Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
5,000
-99.94%
|
$275,000
$55.01 P/Share
|
|
Sep 06
2023
|
Carol D. Karp Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.15 P/Share
|
|
Aug 30
2023
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-81.97%
|
$275,000
$55.39 P/Share
|
|
Aug 30
2023
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$50,000
$10.27 P/Share
|
|
Aug 18
2023
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$285,000
$57.18 P/Share
|
|
Aug 18
2023
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$75,000
$15.04 P/Share
|
|
Aug 16
2023
|
Brandon S. Smith Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,000
-77.68%
|
$236,000
$59.09 P/Share
|
|
Aug 16
2023
|
Brandon S. Smith Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$44,000
$11.12 P/Share
|
|
Aug 16
2023
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-70.19%
|
$116,000
$58.94 P/Share
|
|
Aug 16
2023
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$48,000
$24.9 P/Share
|
|
Aug 02
2023
|
Carol D. Karp Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
5,000
-96.72%
|
$335,000
$67.45 P/Share
|
|
Aug 02
2023
|
Carol D. Karp Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.15 P/Share
|
|
Aug 02
2023
|
Wagner M. Zago Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,000
-97.14%
|
$268,000
$67.53 P/Share
|
|
Aug 02
2023
|
Wagner M. Zago Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$48,000
$12.15 P/Share
|
|
Jul 26
2023
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-74.99%
|
$310,000
$62.62 P/Share
|
|
Jul 26
2023
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$50,000
$10.27 P/Share
|
|
Jul 19
2023
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-89.66%
|
$345,000
$69.52 P/Share
|
|
Jul 19
2023
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$75,000
$15.04 P/Share
|
|
Jul 12
2023
|
Brandon S. Smith Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,000
-90.0%
|
$268,000
$67.67 P/Share
|
|
Jul 12
2023
|
Brandon S. Smith Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$44,000
$11.12 P/Share
|
|
Jul 12
2023
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-97.7%
|
$134,000
$67.84 P/Share
|
|
Jul 12
2023
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$48,000
$24.9 P/Share
|
|
Jul 05
2023
|
Wagner M. Zago Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,000
-87.39%
|
$272,000
$68.34 P/Share
|
|
Jul 05
2023
|
Wagner M. Zago Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$48,000
$12.15 P/Share
|
|
Jul 05
2023
|
Carol D. Karp Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
5,000
-89.66%
|
$340,000
$68.34 P/Share
|
|
Jul 05
2023
|
Carol D. Karp Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.15 P/Share
|
|
Jul 03
2023
|
Dennis J. Selkoe |
SELL
Open market or private sale
|
Direct |
5,000
-63.73%
|
$335,000
$67.43 P/Share
|
|
Jul 03
2023
|
Dennis J. Selkoe |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+38.93%
|
$55,000
$11.33 P/Share
|